Test Directory
| Test Code | ||||
| HYSUQ | ||||
| Test Name | ||||
| Sulfonylureas Qualitative, Hypoglycemia Panel | ||||
| CPT Codes | ||||
| AMA 80377, CMS G0480 | ||||
| Included Tests | ||||
|
||||
| Expected Turnaround Time | ||||
| 4 - 7 days | ||||
| Clinical Utility | ||||
|
Useful for the evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration. Useful for detecting drugs that stimulate insulin secretion. |
||||
| Specimen and Container Info | ||||
|
Specimen Type: Serum
Collection Container: Red Top, Plain Desired Specimen Volume: 1.5 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Patient Preparation | ||||
|
Specimen must be collected during an episode of hypoglycemia. |
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Methodology | ||||
| Liquid Chromatography - Tandem Mass Spectrometry (LC-MS/MS) | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Limitations | ||||
|
This test is not intended for therapeutic drug monitoring but could be used to monitor compliance. Proper interpretation requires that the specimen be collected during or close to the time of a hypoglycemic episode. Drugs will not be detected (and are not likely to be present) if blood is drawn when blood glucose is normal in nondiabetic patients. |
||||
| Alternate Names | ||||
|
||||
| Reference Lab | ||||
| Mayo Clinic Laboratories | ||||
| Testing Schedule | ||||
| Routine, 3 times per week | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.